![logo](/logos/234080.KS.webp)
JW Lifescience Corporation
KRX:234080.KS
10,940 (KRW) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | JW Lifescience Corporation |
Symbool | 234080.KS |
Munteenheid | KRW |
Prijs | 10,980 |
Beurswaarde | 170,020,908,000 |
Dividendpercentage | 4.02% |
52-weken bereik | 10,750 - 14,400 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Sungnam Cha |
Website | https://www.jw-lifescience.co.kr |
An error occurred while fetching data.
Over JW Lifescience Corporation
JW Lifescience Corporation engages in the development, production, and sale of infusion solutions in South Korea and internationally. It offers basic intravenous fluid that comprises water, electrolytes, and glucose; nutrient infusion solution that consist of nutrients, such as amino acids, lipids, proteins, vitamins, and minerals; and special infusion solutions. The
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (KRW)
Cijfers zijn in miljoenen (KRW)